Cardiology
From the Journals
New-onset arrhythmias low in COVID-19 and flu
Overall, incidence of AF/AFL and new onset AF/AFL was similar in COVID-19 vs. influenza. Mortality in those with arrhythmias also increased to a...
From the Journals
How to convince patients muscle pain isn’t a statin Achilles heel: StatinWISE
The strategy seemed to work in this trial: two-thirds of patients who previously rejected statins, perceiving them as the cause of muscle pain,...
From the Journals
Myocardial injury seen on MRI in 54% of recovered COVID-19 patients
Two months after discharge, 54% of hospitalized COVID-19 patients with troponin elevation showed signs of myocardial injury on MRI, some of which...
From the Journals
Study: Central sleep apnea is common in ticagrelor users post ACS
“Whether this particular drug-induced central sleep apnea is consequential” is an open question, says outside expert.
Med Tech Report
Home devices screen for atrial fibrillation
How accurate are they at making a diagnosis?
From the Journals
New light cast on type 2 MI aims to sharpen diagnosis, therapy
A large survey of type 2 MI, triggered when myocardial oxygen demand outstrips supply, points to confusion hindering its diagnosis and treatment...
From the Journals
Long-term CPAP use linked with more physical activity
New research reinforces the health benefits of treating obstructive sleep apnea.
From the Journals
More from DAPA-HF: Dapagliflozin quickly reduces heart failure events
From the Journals
Ivabradine knocks down heart rate, symptoms in POTS
The heart failure drug also may be helpful in treating similar symptoms in patients with long-hauler COVID-19, researchers say.
From the Journals
Cardiovascular trials lose more women than men
The finding amplifies concern about extrapolating results to women, since they are already underrepresented in clinical trials.
News
FDA expands sacubitril/valsartan indication to embrace some HFpEF
The newly approved labeling for sacubitril/valsartan (Entresto) is simply for “chronic heart failure” but almost teasingly adds, “the benefits are...